Heart Rate reduction by IVabradine for improvement of ENDothELial function in patients with coronary artery disease: the RIVENDEL study.

Fabio MangiacapraIginio ColaioriElisabetta RicottiniFrancesco BalducciAntonio CretaChiara DemartiniGiorgio MinottiGermano Di Sciascio

Published in: Clinical research in cardiology : official journal of the German Cardiac Society (2016)

In patients with CAD undergoing complete revascularization with PCI, addition of ivabradine to the standard medical therapy produces a significant improvement in endothelial function. This effect seems to be related to HR reduction. ClinicalTrials.gov number, NCT02681978.

Keyphrases

heart rate
heart rate variability
blood pressure
coronary artery disease
percutaneous coronary intervention
coronary artery bypass grafting
healthcare
acute coronary syndrome
acute myocardial infarction
antiplatelet therapy
st elevation myocardial infarction
heart failure
drug induced